Cme Group INC Form 4 insider transactions

Elizabeth A. Cook, a director of CME Group Inc., acquired 748 shares of Class A Common Stock at a price of $194.1 on June 25, 2024.

Director Deborah J. Lucas acquired 748 shares of CME Group Inc. at a price of $194.1 on June 25, 2024.

Director William W. Hobert reports acquiring 1,237 shares of CME Group Inc. at $194.10 per share.

Director Charles P. Carey sold 3,000 shares of CME Group Inc. stock at a price of $195.44 on June 13, 2024.

Director Daniel Glickman of CME Group Inc. sold 650 shares of Common Stock Class A on June 6, 2024.

Elizabeth A. Cook, a director at CME Group Inc., sold 1,000 shares of Class A Common Stock at a price of $211.52 on May 20, 2024.

Derek Sammann, a Senior Managing Director at CME Group, reported gifting shares of CME Group Class A common stock to his spouse on May 14, 2024.

Director Terry L. Savage sold 2,500 shares of CME Group Inc. Class A Common Stock at a price of $210.6479 on May 13, 2024.

Hilda Harris Piell, a Senior Managing Director and Chief HR Officer at CME Group, recently sold a portion of her holdings in CME Group Class A common stock.

Terrence A. Duffy, Chairman and CEO of CME Group, executed multiple sales of Common Stock Class A on April 29, 2024.

Timothy McCourt, Sr MD Global Head Equity & FX at CME Group, amends his SEC Form 4 to correct a transaction code and reflect adjustments to his beneficially owned shares following a performance share award and tax obligations.

Director William R. Shepard reported acquiring CME Group Inc. Class A common stock through a dividend reinvestment plan and trust.

Timothy McCourt, a Senior Managing Director at CME Group, reported the sale of 35 shares of Common Stock Class A on January 31, 2024.

CME Group's Chief Transformation Officer, Ken Vroman, reports acquisition and disposal of company shares related to a performance share award and tax obligations.

Timothy McCourt, a Senior Managing Director at CME Group, reports acquiring shares from a performance award and surrendering shares for tax obligations.

Julie Holzrichter, Sr MD Chief Operating Officer of CME Group Inc., reports acquisition of shares from a performance award and subsequent disposal to cover tax obligations.

Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., reports the surrender of 282 shares to cover tax obligations on vested restricted stock.

CME Group's Chairman and CEO, Terrence A. Duffy, reports acquiring shares from a performance award and disposing of shares to cover tax obligations.

Julie Winkler, Sr MD Chief Commercial Officer at CME Group, reports acquisition of shares from a performance award and subsequent surrender of shares for tax obligations.

Hilda Harris Piell, Sr MD & Chief HR Officer of CME Group Inc., reports acquiring shares from a performance share award and surrendering shares for tax obligations.

Sunil Cutinho, Chief Information Officer of CME Group, reports the acquisition of shares from a performance award and subsequent surrender of shares for tax obligations.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports acquisition and disposal of company shares to cover tax obligations and from performance share awards.

Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reports acquisition and disposal of company stock to cover tax obligations related to performance share awards and restricted stock vesting.

Derek Sammann, a Senior Managing Director at CME Group, reports the acquisition and disposal of company stock related to a performance share award.

Lynne Fitzpatrick, CFO of CME Group, reports acquisition and disposal of company shares to cover tax obligations and from performance share awards.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reported a gift of 72 shares of Common Stock Class A to his adult children on March 7, 2024.